The Cold Shock of Government Contract Termination for Convenience and How to Survive It with Dignity (and Dollars)

A Sudden Goodbye So there you are, coffee in hand, inbox cleared for once, your team knee-deep in deliverables for a shiny federal contract. Everything’s humming along like a jazz quartet mid-groove until, out of nowhere, you get that email. The Government hereby provides written notice of Termination for Convenience under FAR 52.249-2. And just […]
Powerful Modernizing Defense Acquisitions Strategy for 2025: 7 Game-Changing Shifts Driving Innovation

Modernizing Defense Acquisitions Strategy In an era of rapid technological shifts and increasing global threats, the United States can no longer rely on traditional, slow-moving defense procurement models. The Modernizing Defense Acquisitions Strategy announced by the White House in April 2025 signals a dramatic shift in how America defends its strategic interests and innovates within its defense […]
ODCs vs Indirect Costs vs Direct Labor: Finally Explained Like You’re Five

Ever sat in a government contracts meeting where someone casually tossed out the terms “ODCs,” “indirect costs,” and “direct labor,” and you nodded along like you totally got it—but had zero clue what anyone was talking about? You’re not alone. Federal contracting is a world with its own language. It’s like going to a party where everyone […]
What the Heck is a Technical Assistance Agreement?

Let’s be real. If you’ve ever sat in a meeting about international collaboration, someone probably muttered the words technical assistance agreement like it was a casual formality. But it’s not. It’s a big deal. And if you don’t understand what it is—or worse, if you ignore it—you might be one step away from making a very expensive […]
10 Unsettling Truths About Artificial Intelligence (AI) & Automation in Federal Contracts

Artificial Intelligence (AI) & Automation in Federal ContractsAlright, so here we are, smack dab in a world where the U.S. federal government, the slow-moving behemoth of bureaucracy, is suddenly obsessed with algorithms, machine learning, and automation. It’s weird. And kind of thrilling. Contracts that used to be awarded over months of coffee-fueled handshakes and file […]
Humana’s Deep Ties with Federal Health Contracts (and the Tangled Web Others Want In On)

There’s something almost eerie about walking into a military base clinic and seeing a name like Humana glowing on the signboard, like a giant corporate monolith peering into a tightly run federal machine. And yet, here we are in 2025, still watching Humana Inc. operate as a fixture in U.S. federal healthcare, shaping programs from TRICARE to […]
Top 10 Legal Considerations in Federal Procurement You Can’t Afford to Ignore

Federal procurement is a labyrinth of opportunities—and legal intricacies. For agencies and contractors alike, knowing the legal landscape is just as vital as understanding the bidding process. This post dives deep into the most critical legal considerations in federal procurement, offering clarity on how to manage disputes and litigation when things go awry. Why Legal […]
Leidos Is Blazing a Trail Through Federal Tech

There’s something oddly poetic about a defense contractor winning billions in government work while the rest of the tech world rides the rollercoaster of venture capital drama and AI-powered existential crises. Leidos Holdings Inc. isn’t just thriving—it’s dominating, expanding, and yes, reshaping the very narrative of federal digital modernization. If you’ve been paying attention to the […]
McKesson’s Federal Supply Chain Playbook: Small Business Growth Tips

When it comes to supplying America’s healthcare system, McKesson Corporation plays in the big leagues. As one of the largest pharmaceutical and medical supply distributors in the U.S., McKesson holds massive contracts with the federal government—helping deliver everything from PPE and vaccines to essential medications. But how does a company manage such huge responsibilities, and what can smaller businesses learn […]
Pfizer’s $60M Reality Check: A Chaotic but Crucial Lesson in Compliance

In January 2025, pharmaceutical giant Pfizer made headlines when it agreed to pay nearly $60 million to resolve allegations involving its acquisition, Biohaven Pharmaceutical Holding Company Ltd. The U.S. Department of Justice alleged that Biohaven caused the submission of false claims to federal healthcare programs—including Medicare—by offering kickbacks to providers in exchange for prescribing its migraine treatment, Nurtec ODT. While Pfizer did not admit wrongdoing, the case […]